Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1596800 VANCOUVER, A1

Position in RIGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,920,635
-$327,173 QoQ
Shares Held
49,096
-40.9% QoQ
Ownership
0.263%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 156 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. RIGL ranks #51 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,920,635 49,096
2026-03-31 $2,247,808 83,129
2025-12-31 $4,624,312 107,969
2025-09-30 $6,470,430 228,395
2025-06-30 $2,775,467 148,183
2025-03-31 $2,841,052 157,924
2024-12-31 $2,340,132 139,128
2024-09-30 $1,585,737 98,006
2024-06-30 $621,127 75,563
2024-03-31 $1,084,193 732,563
2023-12-31 $854,058 589,006
2023-09-30 $638,959 591,629
2023-06-30 $774,755 600,586
2023-03-31 $770,078 583,393
2022-12-31 $859,186 572,791